Indraprastha Medical Corp Reports Strong Q3 Results with 25% Profit Growth
Indraprastha Medical Corp delivered comprehensive growth in Q3 with net profit jumping 25% to ₹410 million and revenue rising 13.80% to ₹3.70 billion. The company also achieved operational efficiency gains with EBITDA growing to ₹615 million and EBITDA margin expanding to 16.53% from 16.22%, demonstrating strong cost management and business scalability.
*this image is generated using AI for illustrative purposes only.
Indraprastha Medical Corp has delivered strong financial performance in its third quarter results, showcasing significant growth across key metrics. The healthcare services company reported substantial improvements in revenue, profitability, and operational efficiency, reflecting robust business performance during the quarter.
Comprehensive Financial Performance
The company's financial results demonstrate impressive year-on-year growth across all core parameters:
| Metric | Q3 Current Year | Q3 Previous Year | Growth (%) |
|---|---|---|---|
| Net Profit | ₹410 million | ₹328 million | +25.00% |
| Revenue | ₹3.70 billion | ₹3.25 billion | +13.80% |
| EBITDA | ₹615 million | ₹527 million | +16.70% |
| EBITDA Margin | 16.53% | 16.22% | +31 bps |
Revenue and Profitability Growth
Indraprastha Medical Corp achieved revenue of ₹3.70 billion in Q3, marking a notable increase of 13.80% compared to ₹3.25 billion recorded in the same quarter of the previous year. The company's net profit performance was particularly impressive, reaching ₹410 million compared to ₹328 million in the corresponding quarter of the previous year, representing a substantial 25% year-on-year increase.
Operational Efficiency Improvements
The company demonstrated enhanced operational efficiency with EBITDA rising to ₹615 million from ₹527 million in the previous year, reflecting strong cost management and operational leverage. The EBITDA margin improved to 16.53% from 16.22%, indicating better profitability at the operational level and effective expense management strategies.
Business Performance Analysis
The financial results highlight multiple positive aspects of Indraprastha Medical Corp's business performance. The company has successfully maintained growth momentum across all key financial metrics while enhancing both operational and net profitability. The improvement in EBITDA margin alongside strong profit growth demonstrates the company's ability to scale operations efficiently while maintaining cost discipline in the competitive healthcare services sector.
19
